What is multiple sclerosis life expectancy?

As medicine gains a better understanding of multiple sclerosis (MS), life expectancy continues to improve. Whereas once the condition would be likely to shorten lifespan, recent studies and advances in treatment have provided a more optimistic outlook. On average, people with MS have a life expectancy that’s only about five to 10 years shorter than the general population. This gap has been narrowing, thanks to improved treatments.

Factors that affect life expectancy

Several things can influence the life expectancy of someone living with MS

Type of MS

There are different forms of MS, including relapsing-remitting MS (RRMS), secondary progressive MS (SPMS), and primary progressive MS (PPMS). RRMS tends to have a better prognosis compared to progressive forms, which can be more challenging to manage.

Early diagnosis and treatment

Early and effective treatment can slow the progression of MS and manage symptoms more effectively. Disease-modifying therapies (DMTs) have been shown to reduce the frequency and severity of relapses and may have a positive impact on long-term outcomes.

Overall health

Maintaining a healthy lifestyle can significantly affect life expectancy. This includes managing other health conditions, avoiding smoking, staying physically active, and following a balanced diet. Good mental health and stress management are also crucial.

Access to healthcare

Access to a knowledgeable healthcare team and the latest treatments can make a big difference. Regular check-ups, monitoring, and adjusting treatments as needed can help manage MS more effectively.

Advances in treatment

The landscape of MS treatment has evolved significantly over the past few decades. Disease-modifying therapies (DMTs) are at the forefront of these advances. These medications can alter the course of the disease by reducing the frequency of relapses and slowing down progression.

Additionally, symptom management has improved. Physiotherapy, occupational therapy, and medications to manage specific symptoms like spasticity, fatigue, and bladder issues can enhance quality of life.

Research is ongoing, with new treatments continually being developed and tested. For instance, there is a growing interest in the role of stem cell therapy and other innovative approaches that could potentially repair damaged myelin.

Hematopoietic stem cell transplantation (HSCT) is increasingly being used to reset the immune system and stop the progression of MS, but the treatment is still too new to have any meaningful data demonstrating an effect on life expectancy.

Support

Living with MS is not just about managing physical symptoms; emotional and psychological support is equally important. Support networks, whether through friends, family, or support groups, play a crucial role. Charities like MS-UK offer resources such as peer support services, online activities and a helpline to help those affected by MS lead fulfilling lives.

Multiple sclerosis can present many challenges, but it’s essential to approach the topic of life expectancy with hope and realistic optimism. The average life expectancy for those with MS has improved and continues to do so as research progresses and treatments advance. By focusing on early intervention, healthy lifestyle choices, and comprehensive support, people living with MS can enhance their quality of life and manage the condition more effectively.